NCT06559696View on ClinicalTrials.gov

Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy

PHASE3RecruitingINTERVENTIONAL
Enrollment

722

Participants

Timeline

Start Date

July 15, 2024

Primary Completion Date

July 15, 2032

Study Completion Date

July 15, 2032

Conditions
Breast Cancer
Interventions
RADIATION

internal mammary nodal irradiation

chest wall/whole breast and supraclavicular +-axillary plus internal mammary nodal irradiation (50 Gy in 25 fractions or 40Gy in 15 fractions).

RADIATION

No internal mammary node irradiation

chest wall/whole breast and supraclavicular +-axillary irradiation (50 Gy in 25 fractions or 40Gy in 15 fractions).

Trial Locations (1)

350001

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER